Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | NT5E | P21589 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 13/20 | 0.37 |
| ▸ | CA1 | P00915 | 11/20 | 0.37 |
| ▸ | CA12 | O43570 | 3/20 | 0.37 |
| ▸ | CA7 | P43166 | 3/20 | 0.37 |
| ▸ | CA9 | Q16790 | 3/20 | 0.37 |
| ▸ | CA4 | P22748 | 2/20 | 0.37 |
| ▸ | CA6 | P23280 | 2/20 | 0.37 |
| ▸ | CA5A | P35218 | 2/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.37 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.37 |
| ▸ | F2 | P00734 | 2/20 | 0.36 |
| ▸ | TMPRSS4 | Q9NRS4 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2173061 | 0.86 | TSHR (0.44) | TSHRALDH1A1NT5ELMNACA2 | |
| SCHEMBL437757 | 0.77 | ESR1 (0.50) | ALDH1A1CA2CA1CA12CA7 | |
| SCHEMBL11583429 | 0.75 | LMNA (0.56) | TSHRALDH1A1NT5ELMNACA2 | |
| SCHEMBL22973728 | 0.75 | CES2 (0.36) | TSHRALDH1A1CYP2D6 | |
| SCHEMBL13284437 | 0.75 | CYP1A2 (0.47) | CYP1A2SMN1; SMN2TDP1 | |
| SCHEMBL27190586 | 0.75 | TAAR1 (0.47) | — | |
| SCHEMBL11396462 | 0.75 | LMNA (0.43) | TSHRALDH1A1NT5ELMNACA2 | |
| SCHEMBL2817046 | 0.74 | TDP1 (0.47) | TSHRALDH1A1LMNACA2CA1 | |
| SCHEMBL1806675 | 0.72 | LMNA (0.48) | TSHRALDH1A1NT5ELMNACA2 | |
| SCHEMBL1806678 | 0.72 | CA2 (0.67) | TSHRALDH1A1NT5ELMNACA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7973109-B2 | Crosslinked type layered metal phosphonate compound, production process therefor, non-crosslinked type layered metal phosphonate compound, production process therefor, as well as stock solution | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2011-07-05 | — | — | US | disclosed |
| US-20090093607-A1 | Crosslinked type layered metal phosphonate compound, production process therefor, non-crosslinked type layered metal phosphonate compound, production process therefor, as well as stock solution | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2009-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090093607-A1 | Crosslinked type layered metal phosphonate compound, production process therefor, non-crosslinked type layered metal phosphonate compound, production process therefor, as well as stock solution | WEE1, WEE2, PPIP5K2 | TSHR 4495/4885ALDH1A1 3622/4885NT5E 2489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.